Kotur, Nikola <br/><br/>
Pharmacogenomic Markers of Methotrexate Response in the Consolidation Phase of Pediatric Acute Lymphoblastic Leukemia Treatment.  [electronic resource] 

 -  Genes  04 2020 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2073-4425 
<br/><br/><label>Standard No.: </label>10.3390/genes11040468  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antimetabolites, Antineoplastic--adverse effects<br/>Biomarkers, Tumor--genetics<br/>Child<br/>Child, Preschool<br/>Drug-Related Side Effects and Adverse Reactions--diagnosis<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Genotype<br/>Humans<br/>Infant<br/>Male<br/>Methotrexate--adverse effects<br/>Pharmacogenetics<br/>Polymorphism, Single Nucleotide<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy